Doctors Company Highlights Cardiology Malpractice Risks in New Claims Review
Event summary
- The Doctors Company released a monthly 'Cardiology Claims: February Malpractice Risk Review' on February 3, 2026.
- The review analyzes cardiology malpractice claims to identify contributing factors, negligence allegations, and specific case studies.
- One case study focuses on a failure to diagnose atrial-esophageal fistula after radiofrequency ablation, resulting in a fatal outcome.
- The Doctors Company is the largest physician-owned medical malpractice insurer, serving over 120,000 healthcare professionals and organizations.
The big picture
The Doctors Company’s initiative highlights a growing trend among medical malpractice insurers to proactively address patient safety and mitigate risk through data analysis and targeted interventions. This moves beyond reactive claims handling to a preventative approach, potentially reducing long-term liability costs and enhancing the company’s reputation. The focus on cardiology, a specialty with inherent procedural risks, underscores the need for continuous improvement in clinical practices and communication.
What we're watching
- Clinical Adoption
- The effectiveness of these risk reviews will depend on how readily cardiologists and healthcare leaders incorporate the insights into their practices and protocols, which could impact future claims frequency.
- Regulatory Scrutiny
- Increased awareness of complications like atrial-esophageal fistula following radiofrequency ablation may draw regulatory attention to procedural protocols and physician training standards.
- Data Expansion
- The Doctors Company’s commitment to monthly specialty-focused analyses suggests a broader expansion of data-driven risk management services, potentially impacting their competitive positioning within the medical malpractice insurance market.
Related topics